Metabolic effects of exercise and diet in women with endometrial cancer preparing for staging surgery
Official title: Metabolic Effect of a Physical Activity and Dietary Intervention, and Its Association With Musculoskeletal Changes, in Endometrial Cancer Patients Eligible for Staging Surgery, Compared to Patients Not Receiving the Physical Activity Intervention. A Pilot Study.
Run by National Institute of Cancerología · NCT07025213 · Data updated 2026-11-12
This program will test whether a combined exercise and diet plan helps women with endometrioid endometrial cancer who are awaiting staging surgery improve muscle mass, metabolic markers, and quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | Women only |
| Enrollment | 80 (estimated) |
| Sponsor | National Institute of Cancerología Government |
| Locations | 1 site (México, Tlalpan) |
| Status | Recruiting |
| Started | April 2, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | June 17, 2025 |
| Trial ID | NCT07025213 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–65 with histologically confirmed endometrioid endometrial cancer, BMI >20 kg/m², no prior oncologic treatment, a normal ECG, availability for exercise sessions, and candidates for staging surgery are ideal participants.
✕Probably not a fit
Patients with advanced stage IVB disease, uncontrolled comorbidities (for example uncontrolled hypertension or significant renal dysfunction), prior or concurrent other malignancies, or who cannot participate in exercise or follow the nutritional plan are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional program enrolls adult women with histologically confirmed endometrioid endometrial cancer who are candidates for staging surgery and able to attend supervised exercise sessions. Participants follow a structured physical activity regimen plus a nutritional algorithm prior to surgery, with monitoring of muscle mass and strength, metabolic and inflammatory blood markers, and patient-reported quality of life. Body composition may be evaluated using available CT imaging and functional tests, and safety is screened by ECG and standard labs. The intervention is delivered at the National Institute of Cancerología in Mexico City and compares pre- and post-intervention measures to see if the combined approach improves surgical readiness and metabolic health.
Why it matters
Potential benefit: If successful, the program could increase muscle mass and strength, improve metabolic and inflammation markers, and potentially reduce surgical complications and speed recovery.
How similar studies have gone: Exercise and dietary interventions have improved muscle mass, metabolic markers, and quality of life in other cancer populations, but evidence specifically focused on preoperative endometrial cancer patients is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. -Ability to understand the nature of the study and provide written informed consent. 2. -Women aged over 18 and under 65 years. 3. -Availability to attend exercise sessions. 4. -Willingness and ability to comply with scheduled visits, the proposed nutritional algorithm, treatment plan, and laboratory tests. 5. -Histologically confirmed diagnosis of endometrioid-type endometrial cancer by biopsy. 6. -Normal electrocardiogram (ECG) result. 7. -No prior oncological treatment. 8. -Body mass index (BMI) greater than 20 kg/m². 9. -Availability of a computed tomography (CT) scan. 10. -Candidates for staging surgery. Exclusion Criteria: 1. -Patients with advanced clinical stage or stage IVB disease (according to FIGO 2018 criteria). 2. -Patients with a prior or concurrent malignancy, except non-melanoma skin cancer. 3. -Patients with uncontrolled systemic arterial hypertension. 4. -Patients with renal dysfunction (eGFR ≤ 60 mL/min/1.73 m²). 5. -Patients with uncontrolled psychiatric disorders, including claustrophobia. 6. -Patients with concurrent infections. 7. -Patients with autoimmune disease. 8. -Patients with neuromuscular disease. 9. -Contraindications to physical exercise. 10. -Vulnerable situations (e.g., homelessness preventing adherence to diet, or incarceration).
Where it's running
-
Instituto Nacional de Cancerología
México, Tlalpan, Mexico Recruiting
Study contacts
- Principal investigator: Denisse Castro Eguiluz, PhD — Ministry of Science, Humanities and Technology (SECIHTI)-National Cancer Institute.
- Study coordinator: Denisse Castro Eguiluz, PhD
- Email: adcastro@secihti.mx
- Phone: +52 55 4194 0650
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized navigation to support rural and Black women with endometrial cancer
This pilot tests a tailored patient-navigation program to help rural and Black patients with endometrial cancer access care and services.
-
CR-002 study in adults with advanced solid tumors
This trial tests CR-002 as a single therapy to see if it is safe and tolerable in adults with locally advanced or metastatic solid tumors
-
Methylation markers in self-samples to help detect gynecological cancers
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation or other genetic markers that indicate endometrial, ovarian, vulvar, or vaginal cancers in women who are at risk or have postmenopausal bleeding.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Liquid biopsy screening for early endometrial cancer in regional China
A non-invasive blood test using cell-free DNA is being tested to see if it can detect early endometrial cancer and tell apart benign from malignant uterine lesions.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.